Savvy Hot News, 6/17/22: FTC votes unanimously to increase scrutiny over PBMs ~ FOCUS on INSULIN!

FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022.

The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the rebates and fees paid by drug manufacturers to Pharmacy Benefit Managers (PBMs) to get preferred coverage for their drugs from payers.

The five-member commission, including two Republican commissioners, voted 5–0 to increase the scrutiny of the practice to assess its impact on payers and patients.

Leave a Reply

Your email address will not be published.